Attached files
| file | filename |
|---|---|
| EX-10.46 - FORM OF REGISTRATION RIGHTS AGREEMENT - GUIDED THERAPEUTICS INC | gthp_ex1046.htm |
| EX-10.45 - EQUITY FINANCING AGREEMENT - GUIDED THERAPEUTICS INC | gthp_ex1045.htm |
| EX-5.1 - OPINION ON LEGALITY - GUIDED THERAPEUTICS INC | gthp_ex51.htm |
| S-1 - REGISTRATION STATEMENT - GUIDED THERAPEUTICS INC | gthp_s1.htm |
Exhibit
23.1
We
consent to the inclusion of our report dated April 17, 2018,
relating to the consolidated financial statements of Guided
Therapeutics, Inc. and Subsidiary as of December 31, 2017 and 2016,
and the related consolidated statements of operations,
stockholders’ deficit, and cash flows for the years then
ended, and the related notes to the consolidated financial
statements (collectively, the “consolidated financial
statements”) in this Registration Statement on Form S-1. We
also consent to the reference of us under the heading
“Experts” in such Registration Statement.
Our
report described above contains an explanatory paragraph that
states that the Company has suffered recurring losses from
operations and has an accumulated deficit that raise substantial
doubt about its ability to continue as a going concern. The
consolidated financial statements do not include any adjustments
that might result from the outcome of this
uncertainty.
/s/ UHY
LLP
Sterling
Heights, Michigan
June
11, 2018